References
Filters: Author is Brown, RS Jr [Clear All Filters]
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension. Infect Dis Ther. 2022;11(2):913-924. doi:10.1007/s40121-022-00599-8 .